Cassava Sciences (SAVA) Earnings Date, Estimates & Call Transcripts $31.30 +2.96 (+10.44%) (As of 09/17/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateNov. 5EstimatedActual EPS (Aug. 8) $0.13 Beat By $0.57 Consensus EPS (Aug. 8) -$0.44 Conference Call TranscriptConference Call AudioEarnings Press Release Get Cassava Sciences Earnings AlertsEnter your email address below to receive the latest news and earnings results for SAVA and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueSAVA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SAVA Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceWhy Are Buffett, Bezos, and Musk Fleeing Tech? Here's What To Do Now...The financial world is on high alert. Billionaires like Warren Buffett, Jeff Bezos, and Elon Musk are dumping their tech stocks at a pace we've never seen before. What do they know that's pushing them out? One that Fortune is calling:"The Great Cash Out".Click here to get the details now. Cassava Sciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.51)($0.51)($0.51)Q2 20241($0.48)($0.48)($0.48)Q3 20241($1.37)($1.37)($1.37)Q4 20241($1.56)($1.56)($1.56)FY 20244($3.92)($3.92)($3.92)SAVA Earnings Date and InformationCassava Sciences last announced its earnings data on August 8th, 2024. The reported $0.13 earnings per share for the quarter, topping analysts' consensus estimates of ($0.44) by $0.57. Cassava Sciences has generated ($2.17) earnings per share over the last year (($2.17) diluted earnings per share). Cassava Sciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off prior year's report dates.Read More Cassava Sciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/5/2024(Estimated)------- 8/8/2024Q2 2024($0.44)$0.13+$0.57($2.69)-- 5/10/2024Q1 2024($0.51)($1.41)($0.90)($2.39)-- 2/28/2024Q4 2023($0.40)($0.50)($0.10)($0.50)-- 11/7/2023Q3 2023($0.6429)($0.4357)+$0.2071($0.61)-- 8/3/2023Q2 2023($0.4143)($0.45)($0.0357)($0.63)-- 5/1/2023Q1 2023($0.40)($0.4143)($0.0143)($0.58)-- Get the Latest News and Ratings for SAVA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cassava Sciences and its competitors with MarketBeat's FREE daily newsletter. 2/28/2023Q4 2022($0.4143)($0.3357)+$0.0786($0.47)-- 11/7/2022Q3 2022($0.3357)($0.3643)($0.0286)($0.51)-- 8/3/2022Q2 2022($0.30)($0.3429)($0.0429)($0.48)-- 5/5/2022Q1 2022($0.3071)($0.3143)($0.0071)($0.44)-- 2/28/2022Q4 2021($0.2929)($0.25)+$0.0429($0.35)-- 11/10/2021Q3 2021($0.1071)($0.1714)($0.0643)($0.24)-- 8/3/2021Q2 2021($0.0929)($0.0929)-($0.13)-- 4/20/2021Q1 2021($0.0714)($0.0643)+$0.0071($0.09)--3/22/2021Q4 2020($0.0357)($0.0643)($0.0286)($0.09)-- 11/9/2020Q3 2020($0.05)($0.0429)+$0.0071($0.06)--8/12/2020Q2 2020($0.0429)($0.0357)+$0.0071($0.05)--5/6/2020Q1 2020-($0.0357)($0.0357)($0.05)--3/26/2020Q4 2019($0.0929)($0.0571)+$0.0357($0.08)--10/29/2019Q3 2019($0.0964)($0.0286)+$0.0679($0.04)-- Cassava Sciences Earnings - Frequently Asked Questions When is Cassava Sciences's earnings date? Cassava Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off last year's report dates. Learn more on SAVA's earnings history. Did Cassava Sciences beat their earnings estimates last quarter? In the previous quarter, Cassava Sciences (NASDAQ:SAVA) reported $0.13 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.44) by $0.57. Learn more on analysts' earnings estimate vs. SAVA's actual earnings. How can I listen to Cassava Sciences's earnings conference call? The conference call for Cassava Sciences's latest earnings report can be listened to online. Listen to Conference Call How can I read Cassava Sciences's conference call transcript? The conference call transcript for Cassava Sciences's latest earnings report can be read online. Read Transcript How much profit does Cassava Sciences generate each year? Cassava Sciences (NASDAQ:SAVA) has a recorded net income of -$97.22 million. SAVA has generated -$2.17 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: Collegium Pharmaceutical Earnings Nature's Sunshine Products Earnings Verastem Earnings Verrica Pharmaceuticals Earnings Chimerix Earnings Fortress Biotech Earnings Ultragenyx Pharmaceutical Earnings Apellis Pharmaceuticals Earnings Avidity Biosciences Earnings Immunovant Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 Earnings This page (NASDAQ:SAVA) was last updated on 9/17/2024 by MarketBeat.com Staff From Our PartnersSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredYour Crypto Future is at StakeWhat if I told you that bananas could make you a millionaire? No, this isn't a joke – I'm talking about the...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cassava Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cassava Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
